These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 7994020)

  • 1. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes.
    Trinchieri G
    Blood; 1994 Dec; 84(12):4008-27. PubMed ID: 7994020
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-12 as an inducer of cytotoxic effectors in anti-tumor immunity.
    Kumagai K; Takeda K; Hashimoto W; Seki S; Ogasawara K; Anzai R; Takahashi M; Sato M; Rikiishi H
    Int Rev Immunol; 1997; 14(2-3):229-56. PubMed ID: 9131389
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin-12: a pivotal regulator of cell-mediated immunity.
    Gately MK; Brunda MJ
    Cancer Treat Res; 1995; 80():341-66. PubMed ID: 8821585
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-12 an integral cytokine in the immune response.
    Stern AS; Magram J; Presky DH
    Life Sci; 1996; 58(8):639-54. PubMed ID: 8594314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.
    Tahara H; Lotze MT
    Gene Ther; 1995 Mar; 2(2):96-106. PubMed ID: 7719935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit.
    Chang JT; Segal BM; Nakanishi K; Okamura H; Shevach EM
    Eur J Immunol; 2000 Apr; 30(4):1113-9. PubMed ID: 10760800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.
    Trinchieri G
    Annu Rev Immunol; 1995; 13():251-76. PubMed ID: 7612223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor and antimetastatic activity of interleukin-12.
    Hendrzak JA; Brunda MJ
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():65-83. PubMed ID: 8815011
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-12: an immunoregulatory cytokine produced by B cells and antigen-presenting cells.
    Sartori A; Ma X; Gri G; Showe L; Benjamin D; Trinchieri G
    Methods; 1997 Jan; 11(1):116-27. PubMed ID: 8990097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors.
    Iwata M; Eshima Y; Kagechika H
    Int Immunol; 2003 Aug; 15(8):1017-25. PubMed ID: 12882839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-12: a cytokine with therapeutic potential in oncology and infectious diseases.
    Gately MK; Gubler U; Brunda MJ; Nadeau RR; Anderson TD; Lipman JM; Sarmiento U
    Ther Immunol; 1994 Jun; 1(3):187-96. PubMed ID: 7584494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic enhancement of cell-mediated immunity by interleukin-12 plus interleukin-2: basis for therapy of cutaneous T cell lymphoma.
    Zaki MH; Wysocka M; Everetts SE; Wang KS; French LE; Ritz J; Rook AH
    J Invest Dermatol; 2002 Feb; 118(2):366-71. PubMed ID: 11841558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-12.
    Germann T; Rüde E
    Int Arch Allergy Immunol; 1995 Oct; 108(2):103-12. PubMed ID: 7549496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative feedback regulation of T helper type 1 (Th1)/Th2 cytokine balance via dendritic cell and natural killer T cell interactions.
    Minami K; Yanagawa Y; Iwabuchi K; Shinohara N; Harabayashi T; Nonomura K; Onoé K
    Blood; 2005 Sep; 106(5):1685-93. PubMed ID: 15878981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of interferon-gamma production by IL-12 and IL-18.
    Okamura H; Kashiwamura S; Tsutsui H; Yoshimoto T; Nakanishi K
    Curr Opin Immunol; 1998 Jun; 10(3):259-64. PubMed ID: 9638361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrective effects of interleukin-12 on age-related deficiencies in IFN-gamma production and IL-12Rbeta2 expression in virus-specific CD8+ T cells.
    Zhang Y; Acuna CL; Switzer KC; Song L; Sayers R; Mbawuike IN
    J Interferon Cytokine Res; 2000 Feb; 20(2):235-45. PubMed ID: 10714560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bacterial flagellin in combination with proinflammatory cytokines activates human monocyte-derived dendritic cells to generate cytotoxic T lymphocytes having increased homing signals to cancer.
    Hong CY; Kim SY; Lee HJ; Lee SE; Lim SC; Rhee JH; Lee JJ
    J Immunother; 2014 Jan; 37(1):16-25. PubMed ID: 24316552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 is produced by human uterine natural killer cells but does not affect their production of interferon-gamma.
    Viganò P; Gaffuri B; Somigliana E; Infantino M; Vignali M; Di Blasio AM
    Mol Hum Reprod; 2001 Oct; 7(10):971-7. PubMed ID: 11574666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity.
    Yoo EK; Cassin M; Lessin SR; Rook AH
    J Am Acad Dermatol; 2001 Aug; 45(2):208-16. PubMed ID: 11464181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.